Advanced Search
MyIDEAS: Login

Citations for "Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery"

by Rebecca Henderson & Iain Cockburn

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as in new window
  1. Sangjoon Lee & Jinyoung Kim, 2004. "Research Scientist Productivity and Firm Size: Evidence from Panel Data on Inventors," Econometric Society 2004 Far Eastern Meetings 465, Econometric Society.
  2. Brandon Pope & Andrew Johnson, 2013. "Returns to scope: a metric for production synergies demonstrated for hospital production," Journal of Productivity Analysis, Springer, vol. 40(2), pages 239-250, October.
  3. Ronde, Patrick, 2001. "Technological clusters with a knowledge-based principle: evidence from a Delphi investigation in the French case of the life sciences," Research Policy, Elsevier, vol. 30(7), pages 1041-1057, August.
  4. Lionel Nesta, 2004. "Knowledge and Productivity in the World's Largest Manufacturing Corporations," SPRU Working Paper Series 119, SPRU - Science and Technology Policy Research, University of Sussex.
  5. Andre Jungmittag, 2004. "Innovations, technological specialisation and economic growth in the EU," European Economy - Economic Papers 199, Directorate General Economic and Monetary Affairs (DG ECFIN), European Commission.
  6. Michael J. Orlando, 2002. "Measuring R & D spillovers : on the importance of geographic and technological proximity," Research Working Paper RWP 02-06, Federal Reserve Bank of Kansas City.
  7. Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira, 2003. "Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances," NBER Working Papers 9615, National Bureau of Economic Research, Inc.
  8. Vanhaverbeke, W.P.M. & Beerkens, B.E. & Duysters, G.M., 2003. "Explorative and exploitative learning strategies in technology-based alliance networks," Eindhoven Center for Innovation Studies (ECIS) working paper series 03.22, Eindhoven Center for Innovation Studies (ECIS).
  9. Lopez, Henry & Vanhaverbeke, Wim, 2009. "How innovation intermediaries are shaping the technology market? An analysis of their business model," MPRA Paper 27016, University Library of Munich, Germany, revised 2010.
  10. Paul A. Gompers, 2002. "Corporations and the financing of innovation: The corporate venturing experience," Economic Review, Federal Reserve Bank of Atlanta, issue Q4, pages 1-17.
  11. Brian Jacob & Lars Lefgren, 2007. "The Impact of Research Grant Funding on Scientific Productivity," NBER Working Papers 13519, National Bureau of Economic Research, Inc.
  12. Eduardo S. Schwartz, 2003. "Patents and R&D as Real Options," NBER Working Papers 10114, National Bureau of Economic Research, Inc.
  13. Joshua S. Gans & Fiona E. Murray & Scott Stern, 2013. "Contracting Over the Disclosure of Scientific Knowledge: Intellectual Property and Academic Publication," NBER Working Papers 19560, National Bureau of Economic Research, Inc.
  14. Nicola Lacetera, 2000. "Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry," KITeS Working Papers 122, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Dec 2000.
  15. Leiponen, Aija, 2005. "Skills and innovation," International Journal of Industrial Organization, Elsevier, vol. 23(5-6), pages 303-323, June.
  16. Coronado, Daniel & Acosta, Manuel & Fernández, Ana, 2008. "Attitudes to innovation in peripheral economic regions," Research Policy, Elsevier, vol. 37(6-7), pages 1009-1021, July.
  17. Agrawal, Ajay & Cockburn, Iain M & Galasso, Alberto & Oettl, Alexander, 2013. "Why are some regions more innovative than others? The role of firm size diversity," CEPR Discussion Papers 9766, C.E.P.R. Discussion Papers.
  18. James D. Adams & J. Roger Clemmons & Paula E. Stephan, 2006. "How Rapidly Does Science Leak Out?," Rensselaer Working Papers in Economics 0612, Rensselaer Polytechnic Institute, Department of Economics.
  19. Thomas Bolli & Martin Wörter, 2013. "Technological Diversification and Innovation Performance," KOF Working papers 13-336, KOF Swiss Economic Institute, ETH Zurich.
  20. Tingvall, Patrik & Karpaty, Patrik, 2011. "Offshoring and Home Country R&D," Ratio Working Papers 180, The Ratio Institute.
  21. Vanhaverbeke, W. & Beerkens, B. & Duysters, G., 2001. "Technological capability building through networking strategies within high-tech industries," Eindhoven Center for Innovation Studies (ECIS) working paper series 01.15, Eindhoven Center for Innovation Studies (ECIS).
  22. Yves Breitmoser & Jonathan H. W. Tan & Daniel John Zizzo, 2008. "Understanding Perpetual R&D Races," Working Papers 08-22, Centre for Competition Policy, University of East Anglia.
  23. Zuniga, Pluvia & Crespi, Gustavo, 2013. "Innovation strategies and employment in Latin American firms," Structural Change and Economic Dynamics, Elsevier, vol. 24(C), pages 1-17.
  24. Moses Acquaah, 2003. "Corporate Management, Industry Competition and the Sustainability of Firm Abnormal Profitability," Journal of Management and Governance, Springer, vol. 7(1), pages 57-85, March.
  25. James W Hughes & Michael J Moore & Edward A Snyder, 2003. "Napsterizing Pharmaceuticals: Access, Innovation and Consumer Welfare," Levine's Working Paper Archive 618897000000000555, David K. Levine.
  26. de Rassenfosse, Gaétan, 2013. "Do firms face a trade-off between the quantity and the quality of their inventions?," Research Policy, Elsevier, vol. 42(5), pages 1072-1079.
  27. Cassiman, Bruno & Perez-Castrillo, David & Veugelers, Reinhilde, 2002. "Endogenizing know-how flows through the nature of R&D investments," International Journal of Industrial Organization, Elsevier, vol. 20(6), pages 775-799, June.
  28. Lee Branstetter & Reiko Aoki, 2005. "Is Academic Science Raising Innovative Productivity? Theory and Evidence from Firm-Level Data," Hi-Stat Discussion Paper Series d05-86, Institute of Economic Research, Hitotsubashi University.
  29. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  30. Elena Cefis, 2008. "The Impact of M&A on Technology Sourcing Strategies," LEM Papers Series 2008/25, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  31. Takalo, Tuomas & Tanayama, Tanja & Toivanen, Otto, 2008. "Evaluating innovation policy: a structural treatment effect model of R&D subsidies," Research Discussion Papers 7/2008, Bank of Finland.
  32. Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," MERIT Working Papers 015, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  33. Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
  34. Lim, Kwanghui, 2004. "The relationship between research and innovation in the semiconductor and pharmaceutical industries (1981-1997)," Research Policy, Elsevier, vol. 33(2), pages 287-321, March.
  35. José García-Quevedo & Gabriele Pellegrino & Marco Vivarelli, 2011. "The determinants of YICs’ R&Dactivity," Working Papers 2011/31, Institut d'Economia de Barcelona (IEB).
  36. Kuo-Feng Huang & Chwo-Ming Yu, 2011. "The effect of competitive and non-competitive R&D collaboration on firm innovation," The Journal of Technology Transfer, Springer, vol. 36(4), pages 383-403, August.
  37. Lee Branstetter & Mariko Sakakibara, 1997. "Japanese Research Consortia: A Microeconometric Analysis of Industrial Policy," NBER Working Papers 6066, National Bureau of Economic Research, Inc.
  38. Giulio Bottazzi & Tatiana Plotnikova, 2010. "Productivity and Heterogeneous Knowledge: Exploring the Relationship in a Sample of Drug Developers," Jena Economic Research Papers 2010-044, Friedrich-Schiller-University Jena, Max-Planck-Institute of Economics.
  39. Robert S. Gibbons, 2010. "Inside Organizations: Pricing, Politics, and Path Dependence," Levine's Working Paper Archive 661465000000000249, David K. Levine.
  40. Wilfried Zidorn & Marcus Wagner, 2012. "Too Much of a Good Thing: The Role of Alliance Portfolio Diversity for Innovation Output in the Biotechnology Industry," DRUID Working Papers 12-10, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  41. Bruno Cassiman & Reinhilde Veugelers, 1998. "R&D cooperation and spillovers: Some empirical evidence," Economics Working Papers 328, Department of Economics and Business, Universitat Pompeu Fabra.
  42. Hauser, John R., 1996. "The role of mathematical models in the study of product development," Working papers #148-96. Working paper (S, Massachusetts Institute of Technology (MIT), Sloan School of Management.
  43. Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," Levine's Working Paper Archive 228400000000000002, David K. Levine.
  44. E. Cefis & A. Sabidussi & E.J.J. Schenk, 2007. "Do mergers of potentially dominant firms foster innovation? An empirical analysis for the manufacturing sector," Working Papers 07-20, Utrecht School of Economics.
  45. Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.
  46. Tsai, Kuen-Hung & Wang, Jiann-Chyuan, 2009. "External technology sourcing and innovation performance in LMT sectors: An analysis based on the Taiwanese Technological Innovation Survey," Research Policy, Elsevier, vol. 38(3), pages 518-526, April.
  47. Ornaghi, Carmine, 2009. "Mergers and innovation in big pharma," International Journal of Industrial Organization, Elsevier, vol. 27(1), pages 70-79, January.
  48. Lee G. Branstetter & Mariko Sakakibara, 2000. "When Do Research Consortia Work Well and Why? Evidence from Japanese Panel Data," NBER Working Papers 7972, National Bureau of Economic Research, Inc.
  49. Timothy Bresnahan & Jonathan Levin, 2012. "Vertical Integration and Market Structure
    [The Handbook of Organizational Economics]
    ," Introductory Chapters, Princeton University Press.
  50. Benjamin F. Jones, 2005. "The burden of knowledge and the ‘death of the Renaissance man’: Is innovation getting harder?," Proceedings, Federal Reserve Bank of San Francisco.
  51. Rivera-Huerta, René & Dutrénit, Gabriela & Ekboir, Javier Mario & Sampedro, José Luis & Vera-Cruz, Alexandre O., 2011. "Do linkages between farmers and academic researchers influence researcher productivity? The Mexican case," Research Policy, Elsevier, vol. 40(7), pages 932-942, September.
  52. Gilsing, Victor & Nooteboom, Bart & Vanhaverbeke, Wim & Duysters, Geert & van den Oord, Ad, 2008. "Network embeddedness and the exploration of novel technologies: Technological distance, betweenness centrality and density," Research Policy, Elsevier, vol. 37(10), pages 1717-1731, December.
  53. Nooteboom, B. & Vanhaverbeke, W.P.M. & Duijsters, G.M. & Gilsing, V.A. & Oord, A., 2006. "Optimal Cognitive Distance and Absorptive Capacity," Discussion Paper 2006-33, Tilburg University, Center for Economic Research.
  54. Frank R. Lichtenberg, 2001. "The Allocation of Publicly Funded Biomedical Research," NBER Chapters, in: Medical Care Output and Productivity, pages 565-590 National Bureau of Economic Research, Inc.
  55. Lionel Nesta, 2005. "Knowledge and Productivity in the World's Largest Manufacturing Corporations," Sciences Po publications 2005-17, Sciences Po.
  56. Leten, Bart & Kelchtermans, Stijn & Belderbos, Ren, 2010. "Internal Basic Research, External Basic Research and the Technological Performance of Pharmaceutical Firms," Working Papers 2010/12, Hogeschool-Universiteit Brussel, Faculteit Economie en Management.
  57. Olena Senyuta & Kresimir Zigic, 2012. "Managing Spillovers: An Endogenous Sunk Cost Approach," CERGE-EI Working Papers wp472, The Center for Economic Research and Graduate Education - Economic Institute, Prague.
  58. Banri ITO & Tatsufumi YAMAGATA, 2007. "Who Develops Innovations In Medicine For The Poor? Trends In Patent Applications Related To Medicines For Hiv/Aids, Tuberculosis, Malaria, And Neglected Diseases," The Developing Economies, Institute of Developing Economies, vol. 45(2), pages 141-171.
  59. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
  60. Giulio Bottazzi & Angelo Secchi, 2006. "Explaining the distribution of firm growth rates," RAND Journal of Economics, RAND Corporation, vol. 37(2), pages 235-256, 06.
  61. Martin Falk, 2012. "Quantile estimates of the impact of R&D intensity on firm performance," Small Business Economics, Springer, vol. 39(1), pages 19-37, July.
  62. Michael Fung, 2004. "Technological Opportunity and Productivity of R&D Activities," Journal of Productivity Analysis, Springer, vol. 21(2), pages 167-181, March.
  63. Ajay Agrawal & Iain M. Cockburn, 2002. "University Research, Industrial R&D, and the Anchor Tenant Hypothesis," NBER Working Papers 9212, National Bureau of Economic Research, Inc.
  64. Waheed, Abdul, 2011. "Size, competition, and innovative activities: a developing world perspective," MERIT Working Papers 052, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  65. Marcela Miozzo & Lori DiVito & Panos Desyllas, 2011. "Cross-border acquisitions of science-based firms: Their effect on innovation in the acquired firm and the local science," DRUID Working Papers 11-17, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  66. James D. Adams, 2004. "Industrial R&D Laboratories: Windows on Black Boxes?," Rensselaer Working Papers in Economics 0419, Rensselaer Polytechnic Institute, Department of Economics.
  67. Aharonson, Barak S. & Baum, Joel A.C. & Plunket, Anne, 2008. "Inventive and uninventive clusters: The case of Canadian biotechnology," Research Policy, Elsevier, vol. 37(6-7), pages 1108-1131, July.
  68. Amy Diduch, 2010. "Patents and R&D: a Classroom Experiment," International Review of Economic Education, Economics Network, University of Bristol, vol. 9(2), pages 67-83.
  69. Van de Vrande, Vareska & Vanhaverbeke, Wim & Duysters, Geert, 2009. "Additivity and complementarity in external technology sourcing: The added value of corporate venture capital investments," MPRA Paper 26419, University Library of Munich, Germany, revised 2010.
  70. Bertoni, Fabio & Tykvová, Tereza, 2012. "Which form of venture capital is most supportive of innovation?," ZEW Discussion Papers 12-018, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research.
  71. Oscar Alfranca, 2005. "Private R&D and Spillovers in European Agriculture," International Advances in Economic Research, Springer, vol. 11(2), pages 201-213, May.
  72. Bruno Cassiman & Reinhilde Veugelers, 1998. "Complementarity between technology make and buy in innovation strategies: Evidence from Belgiam manufacturing firms," Economics Working Papers 279, Department of Economics and Business, Universitat Pompeu Fabra.
  73. Boris Lokshin & René Belderbos & Martin Carree, 2008. "The Productivity Effects of Internal and External R&D: Evidence from a Dynamic Panel Data Model," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 70(3), pages 399-413, 06.
  74. Luo, Xiaowei Rose & Koput, Kenneth W. & Powell, Walter W., 2009. "Intellectual capital or signal? The effects of scientists on alliance formation in knowledge-intensive industries," Research Policy, Elsevier, vol. 38(8), pages 1313-1325, October.
  75. Deng, Yi, 2008. "The value of knowledge spillovers in the U.S. semiconductor industry," International Journal of Industrial Organization, Elsevier, vol. 26(4), pages 1044-1058, July.
  76. Cassiman, Bruno & Veugelers, Reinhilde & Zuniga, Pluvia, 2007. "Science linkages and innovation performance: An analysis on CIS-3 firms in Belgium," IESE Research Papers D/671, IESE Business School.
  77. Tuomas Takalo & Tanja Tanayama & Otto Toivanen, 2005. "Selection Or Self-Rejection? Applications Into A Treatment," Industrial Organization 0510002, EconWPA.
  78. Takalo, Tuomas & Kanniainen, Vesa, 2000. "Do patents slow down technological progress?: Real options in research, patenting, and market introduction," International Journal of Industrial Organization, Elsevier, vol. 18(7), pages 1105-1127, October.
  79. Josh Lerner & Alexander Tsai, 2000. "Do Equity Financing Cycles Matter? Evidence from Biotechnology Alliances," NBER Working Papers 7464, National Bureau of Economic Research, Inc.
  80. Gilbert, Brett Anitra & McDougall, Patricia P. & Audretsch, David B., 2008. "Clusters, knowledge spillovers and new venture performance: An empirical examination," Journal of Business Venturing, Elsevier, vol. 23(4), pages 405-422, July.
  81. Lerner, Josh, 2006. "The new new financial thing: The origins of financial innovations," Journal of Financial Economics, Elsevier, vol. 79(2), pages 223-255, February.
  82. Benjamin F. Jones, 2005. "The Burden of Knowledge and the 'Death of the Renaissance Man': Is Innovation Getting Harder?," NBER Working Papers 11360, National Bureau of Economic Research, Inc.
  83. Rothaermel, Frank T. & Thursby, Marie, 2007. "The nanotech versus the biotech revolution: Sources of productivity in incumbent firm research," Research Policy, Elsevier, vol. 36(6), pages 832-849, July.
  84. Mahmood, Ishtiaq P. & Mitchell, Will, 2002. "Two Faces: Effects of Business Groups on Innovation in Emerging Economies," CEI Working Paper Series 2002-14, Center for Economic Institutions, Institute of Economic Research, Hitotsubashi University.
  85. Ornaghi, Carmine, 2006. "Mergers and innovation: the case of the pharmaceutical industry," Discussion Paper Series In Economics And Econometrics 0605, Economics Division, School of Social Sciences, University of Southampton.
  86. Casper, Steven & Matraves, Catherine, 2003. "Institutional frameworks and innovation in the German and UK pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1865-1879, December.
  87. Josh Lerner & Robert P. Merges, 1997. "The Control of Strategic Alliances: An Empirical Analysis of Biotechnology Collaborations," NBER Working Papers 6014, National Bureau of Economic Research, Inc.
  88. Davide Consoli & Dioni Elche, 2013. "The evolving knowledge base of professional service sectors," Journal of Evolutionary Economics, Springer, vol. 23(2), pages 477-501, April.
  89. Rivera, Rene & Sampedro, Jose Luis & Dutrenit, Gabriela & Ekboir, Javier Mario & Vera-Cruz, Alexandre O., 2009. "How productive are academic researchers in agriculture-related sciences? The Mexican case," MERIT Working Papers 038, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  90. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series 1999/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  91. Bharant N. Anand & Alexander Galetovic, 1998. "Weak Property Rights and hold-up in R&D," Documentos de Trabajo 39, Centro de Economía Aplicada, Universidad de Chile.
  92. Henderson, Rebecca. & Cockburn, Iain., 1994. "Measuring competence? : exploring firm effects in pharmaceutical research," Working papers 3712-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  93. Ashish Arora & Sharon Belenzon & Luis A. Rios, 2011. "The Organization of R&D in American Corporations: The Determinants and Consequences of Decentralization," NBER Working Papers 17013, National Bureau of Economic Research, Inc.
  94. Iain Cockburn & Rebecca Henderson & Scott Stern, 1999. "Balancing Incentives: The Tension Between Basic and Applied Research," NBER Working Papers 6882, National Bureau of Economic Research, Inc.
  95. Dahlander, Linus & Gann, David M., 2010. "How open is innovation?," Research Policy, Elsevier, vol. 39(6), pages 699-709, July.
  96. Häussler, Carolin, 2006. "Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 189, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
  97. Galende, Jesus & de la Fuente, Juan Manuel, 2003. "Internal factors determining a firm's innovative behaviour," Research Policy, Elsevier, vol. 32(5), pages 715-736, May.
  98. Gonzalez-Brambila, Claudia & Veloso, Francisco M., 2007. "The determinants of research output and impact: A study of Mexican researchers," Research Policy, Elsevier, vol. 36(7), pages 1035-1051, September.
  99. Ciftci, Mustafa & Cready, William M., 2011. "Scale effects of R&D as reflected in earnings and returns," Journal of Accounting and Economics, Elsevier, vol. 52(1), pages 62-80, June.
  100. repec:wip:wpaper:4 is not listed on IDEAS
  101. Matraves, Catherine, 1999. "Market Structure, R&D and Advertising in the Pharmaceutical Industry," Journal of Industrial Economics, Wiley Blackwell, vol. 47(2), pages 169-94, June.
  102. Lee, Jeho & Park, Seung Ho & Ryu, Young & Baik, Yoon-Suk, 2010. "A hidden cost of strategic alliances under Schumpeterian dynamics," Research Policy, Elsevier, vol. 39(2), pages 229-238, March.
  103. Wu, Jianfeng & Shanley, Mark T., 2009. "Knowledge stock, exploration, and innovation: Research on the United States electromedical device industry," Journal of Business Research, Elsevier, vol. 62(4), pages 474-483, April.
  104. Bertoni, Fabio & Tykvová, Tereza, 2013. "Which form of venture capital is most supportive of innovation? Evidence from European biotechnology companies," FZID Discussion Papers 69-2013, University of Hohenheim, Center for Research on Innovation and Services (FZID).
  105. Alfonso Gambardella & Marco Giarratana, 2004. "Chandlerian Firms vs. Entrepreneurship," LEM Papers Series 2004/12, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  106. Colombo, Massimo G. & Rabbiosi, Larissa, 2014. "Technological similarity, post-acquisition R&D reorganization, and innovation performance in horizontal acquisitions," Research Policy, Elsevier, vol. 43(6), pages 1039-1054.
  107. Andrea Canidio, 2012. "The Allocation of Scientific Talent," CEU Working Papers 2012_7, Department of Economics, Central European University, revised 15 May 2012.
  108. Nicolas Figueroa & Carlos J. Serrano, 2013. "Patent Trading Flows of Small and Large Firms," NBER Working Papers 18982, National Bureau of Economic Research, Inc.
  109. Breschi, Stefano & Lissoni, Francesco & Malerba, Franco, 2003. "Knowledge-relatedness in firm technological diversification," Research Policy, Elsevier, vol. 32(1), pages 69-87, January.
  110. TAKECHI Kazutaka, 2008. "International Strategic Alliances for Local Market Entry: Direct Launches versus Marketing Alliances in Pharmaceuticals," Discussion papers 08022, Research Institute of Economy, Trade and Industry (RIETI).
  111. Ruth, Derek & Iyer, Dinesh N. & Sharp, Barton M., 2013. "Motivation and ability in the decision to acquire," Journal of Business Research, Elsevier, vol. 66(11), pages 2287-2293.
  112. Lee G. Branstetter & Mariko Sakakibara, 2002. "When Do Research Consortia Work Well and Why? Evidence from Japanese Panel Data," American Economic Review, American Economic Association, vol. 92(1), pages 143-159, March.
  113. Steven Casper & Catherine Matraves, 1997. "Corporate Governance and Firm Strategy in the Pharmaceutical Industry," CIG Working Papers FS IV 97-20, Wissenschaftszentrum Berlin (WZB), Research Unit: Competition and Innovation (CIG).
  114. Mary K. Olson, 2000. "Regulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 9(3), pages 363-395, 06.
  115. repec:spo:wpecon:info:hdl:2441/7187 is not listed on IDEAS
  116. Leiponen, Aija, 2003. "Organizational Knowledge and Innovation in Business Services," Working Papers 127228, Cornell University, Department of Applied Economics and Management.
  117. Emmanuel Duguet & Stéphanie Monjon, 2004. "Is innovation persistent at the firm Level . An econometric examination comparing the propensity score and regression methods," Cahiers de la Maison des Sciences Economiques v04075, Université Panthéon-Sorbonne (Paris 1).
  118. Veugelers, Reinhilde & Cassiman, Bruno, 1999. "Make and buy in innovation strategies: evidence from Belgian manufacturing firms," Research Policy, Elsevier, vol. 28(1), pages 63-80, January.
  119. Patricia M. Danzon & Eric L. Keuffel, 2013. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484 National Bureau of Economic Research, Inc.
  120. Talke, Katrin & Salomo, Sören & Rost, Katja, 2010. "How top management team diversity affects innovativeness and performance via the strategic choice to focus on innovation fields," Research Policy, Elsevier, vol. 39(7), pages 907-918, September.
  121. Audretsch, David B & Lehmann, Erik E, 2005. "Entrepreneurial Access and Absorption of Knowledge Spillovers: Strategic Board and Managerial Composition for Competitive Advantage," CEPR Discussion Papers 5335, C.E.P.R. Discussion Papers.
  122. Lionel Nesta, 2005. "Knowledge and Productivity in the World's Largest Manufacturing Corporations Level:Panel Data analysis on Compustat and Patent data," Documents de Travail de l'OFCE 2005-17, Observatoire Francais des Conjonctures Economiques (OFCE).
  123. Tannista Banerjee & Stephen Martin, 2013. "Pharmaceutical regulation and innovative performance: a decision-theoretic model," Auburn Economics Working Paper Series auwp2013-21, Department of Economics, Auburn University.
  124. Leiponen, Aija, 2003. "The Choice of Organizational Form for Collaborative Innovation," Working Papers 127230, Cornell University, Department of Applied Economics and Management.
  125. Beneito, Pilar, 2003. "Choosing among alternative technological strategies: an empirical analysis of formal sources of innovation," Research Policy, Elsevier, vol. 32(4), pages 693-713, April.
  126. M. Sirgy & Dong-Jin Lee & Grace Yu, 2011. "Consumer Sovereignty in Healthcare: Fact or Fiction?," Journal of Business Ethics, Springer, vol. 101(3), pages 459-474, July.
  127. Lee Branstetter & Kwon Hyeog Ug, 2004. "The Restructuring Of Japanese Research And Development: The Increasing Impact Of Science On Japanese R&D," Discussion papers 04021, Research Institute of Economy, Trade and Industry (RIETI).
  128. Pluvia Zuniga, 2011. "The State of Patenting at Research Institutions in Developing Countries: Policy Approaches and Practices," WIPO Economic Research Working Papers 04, World Intellectual Property Organization - Economics and Statistics Division, revised Dec 2011.
  129. Agrawal, Ajay & Cockburn, Iain & Galasso, Alberto & Oettl, Alexander, 2014. "Why are some regions more innovative than others? The role of small firms in the presence of large labs," Journal of Urban Economics, Elsevier, vol. 81(C), pages 149-165.
  130. Huang, Kuo-Feng, 2011. "Technology competencies in competitive environment," Journal of Business Research, Elsevier, vol. 64(2), pages 172-179, February.
  131. Dietmar Harhoff, 1997. "Incentives to Innovate: A Structural Model of Oligopoly (available only in German!)," CIG Working Papers FS IV 97-09, Wissenschaftszentrum Berlin (WZB), Research Unit: Competition and Innovation (CIG).
  132. Liu, Runjuan & Rosell, Carlos, 2013. "Import competition, multi-product firms, and basic innovation," Journal of International Economics, Elsevier, vol. 91(2), pages 220-234.
  133. Michael J. Orlando, 2000. "On the importance of geographic and technological proximity for R&D spillovers : an empirical investigation," Research Working Paper RWP 00-02, Federal Reserve Bank of Kansas City.
  134. Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
  135. Cloodt, Myriam & Hagedoorn, John & Van Kranenburg, Hans, 2006. "Mergers and acquisitions: Their effect on the innovative performance of companies in high-tech industries," Research Policy, Elsevier, vol. 35(5), pages 642-654, June.
  136. Soh, Pek-Hooi, 2003. "The role of networking alliances in information acquisition and its implications for new product performance," Journal of Business Venturing, Elsevier, vol. 18(6), pages 727-744, November.
  137. Desyllas, Panos & Hughes, Alan, 2010. "Do high technology acquirers become more innovative?," Research Policy, Elsevier, vol. 39(8), pages 1105-1121, October.
  138. Quintana-Garci­a, Cristina & Benavides-Velasco, Carlos A., 2008. "Innovative competence, exploration and exploitation: The influence of technological diversification," Research Policy, Elsevier, vol. 37(3), pages 492-507, April.
  139. Tannista Banerjee & Ralph Siebert, 2014. "The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 4567, CESifo Group Munich.
  140. Schmiedeberg, Claudia, 2008. "Complementarities of innovation activities: An empirical analysis of the German manufacturing sector," Research Policy, Elsevier, vol. 37(9), pages 1492-1503, October.